Schizophrenia Clinical Trials

Find Schizophrenia Clinical Trials Near You

Culturally-adapted Cognitive-behavioural Therapy for Black Sub-Saharan African and Caribbean People Experiencing Psychosis: A Case Series

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this case series study is to learn if culturally-adapted cognitive-behavioural therapy is practical, acceptable and safe among Black Sub-Saharan African and Caribbean people experiencing psychosis. The main question it aims to answer is: Is culturally-adapted CBT for psychosis feasible, acceptable to and safe for Black Sub-Saharan African and Caribbean people experiencing psychosis? Participants will be asked to: * Answer some questionnaires about how things are at the moment * Attend up to 16 sessions of therapy * Answer the same questionnaires to see what has changed, if anything * Complete a semi-structured interview about their expectations and experience of therapy

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• Service users who identify as Black British, Black Caribbean, Black African, African-Caribbean or Mixed African/Caribbean with at least one parent and/or grandparent born in a Sub-Saharan African or Caribbean country

• People with a current ICD-10 schizophrenia spectrum disorder diagnosis, or who are currently receiving or have received support from an Early Intervention in Psychosis team

• 16 years or older

• Sufficient understanding of English to complete study measures and engage with CBTp

Locations
Other Locations
United Kingdom
Greater Manchester Mental Health NHS Foundation Trust
RECRUITING
Manchester
Contact Information
Primary
Peter Panayi
peter.panayi@manchester.ac.uk
+44161 306 6000
Time Frame
Start Date: 2026-02-24
Estimated Completion Date: 2026-12
Participants
Target number of participants: 6
Treatments
Experimental: Therapy
Related Therapeutic Areas
Sponsors
Leads: University of Manchester

This content was sourced from clinicaltrials.gov